IBDEI1GN ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23619,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23619,1,3,0)
 ;;=3^Suicidal Ideations
 ;;^UTILITY(U,$J,358.3,23619,1,4,0)
 ;;=4^R45.851
 ;;^UTILITY(U,$J,358.3,23619,2)
 ;;=^5019474
 ;;^UTILITY(U,$J,358.3,23620,0)
 ;;=T14.91XA^^79^1020^4
 ;;^UTILITY(U,$J,358.3,23620,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23620,1,3,0)
 ;;=3^Suicide Attempt,Initial Encntr
 ;;^UTILITY(U,$J,358.3,23620,1,4,0)
 ;;=4^T14.91XA
 ;;^UTILITY(U,$J,358.3,23620,2)
 ;;=^5151779
 ;;^UTILITY(U,$J,358.3,23621,0)
 ;;=T14.91XD^^79^1020^6
 ;;^UTILITY(U,$J,358.3,23621,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23621,1,3,0)
 ;;=3^Suicide Attempt,Subsequent Encntr
 ;;^UTILITY(U,$J,358.3,23621,1,4,0)
 ;;=4^T14.91XD
 ;;^UTILITY(U,$J,358.3,23621,2)
 ;;=^5151780
 ;;^UTILITY(U,$J,358.3,23622,0)
 ;;=T14.91XS^^79^1020^5
 ;;^UTILITY(U,$J,358.3,23622,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23622,1,3,0)
 ;;=3^Suicide Attempt,Sequela
 ;;^UTILITY(U,$J,358.3,23622,1,4,0)
 ;;=4^T14.91XS
 ;;^UTILITY(U,$J,358.3,23622,2)
 ;;=^5151781
 ;;^UTILITY(U,$J,358.3,23623,0)
 ;;=Z91.52^^79^1020^1
 ;;^UTILITY(U,$J,358.3,23623,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23623,1,3,0)
 ;;=3^Personal Hx of Non-Suicidal Self-Harm
 ;;^UTILITY(U,$J,358.3,23623,1,4,0)
 ;;=4^Z91.52
 ;;^UTILITY(U,$J,358.3,23623,2)
 ;;=^5161318
 ;;^UTILITY(U,$J,358.3,23624,0)
 ;;=Z91.52^^79^1020^2
 ;;^UTILITY(U,$J,358.3,23624,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23624,1,3,0)
 ;;=3^Personal Hx of Suicidal Behavior     
 ;;^UTILITY(U,$J,358.3,23624,1,4,0)
 ;;=4^Z91.52
 ;;^UTILITY(U,$J,358.3,23624,2)
 ;;=^5161318
 ;;^UTILITY(U,$J,358.3,23625,0)
 ;;=Z51.81^^79^1021^19
 ;;^UTILITY(U,$J,358.3,23625,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23625,1,3,0)
 ;;=3^Therapeutic Drug Level Monitoring
 ;;^UTILITY(U,$J,358.3,23625,1,4,0)
 ;;=4^Z51.81
 ;;^UTILITY(U,$J,358.3,23625,2)
 ;;=^5063064
 ;;^UTILITY(U,$J,358.3,23626,0)
 ;;=Z79.01^^79^1021^15
 ;;^UTILITY(U,$J,358.3,23626,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23626,1,3,0)
 ;;=3^Long Term Current Use of Anticoagulants
 ;;^UTILITY(U,$J,358.3,23626,1,4,0)
 ;;=4^Z79.01
 ;;^UTILITY(U,$J,358.3,23626,2)
 ;;=^5063330
 ;;^UTILITY(U,$J,358.3,23627,0)
 ;;=I48.0^^79^1021^7
 ;;^UTILITY(U,$J,358.3,23627,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23627,1,3,0)
 ;;=3^Atrial Fibrillation,Paroxysmal
 ;;^UTILITY(U,$J,358.3,23627,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,23627,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,23628,0)
 ;;=Z86.711^^79^1021^17
 ;;^UTILITY(U,$J,358.3,23628,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23628,1,3,0)
 ;;=3^Personal Hx of Pulmonary Embolism
 ;;^UTILITY(U,$J,358.3,23628,1,4,0)
 ;;=4^Z86.711
 ;;^UTILITY(U,$J,358.3,23628,2)
 ;;=^5063474
 ;;^UTILITY(U,$J,358.3,23629,0)
 ;;=Z95.2^^79^1021^18
 ;;^UTILITY(U,$J,358.3,23629,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23629,1,3,0)
 ;;=3^Presence of Prosthetic Heart Valve
 ;;^UTILITY(U,$J,358.3,23629,1,4,0)
 ;;=4^Z95.2
 ;;^UTILITY(U,$J,358.3,23629,2)
 ;;=^5063670
 ;;^UTILITY(U,$J,358.3,23630,0)
 ;;=I48.92^^79^1021^9
 ;;^UTILITY(U,$J,358.3,23630,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23630,1,3,0)
 ;;=3^Atrial Flutter,Unspec
 ;;^UTILITY(U,$J,358.3,23630,1,4,0)
 ;;=4^I48.92
 ;;^UTILITY(U,$J,358.3,23630,2)
 ;;=^5007230
 ;;^UTILITY(U,$J,358.3,23631,0)
 ;;=D68.8^^79^1021^11
 ;;^UTILITY(U,$J,358.3,23631,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23631,1,3,0)
 ;;=3^Coagulation Defects,Oth Specified
